Beyond the Aryl Hydrocarbon Receptor: Pathway Interactions in the Hepatotoxicity of 2,3,7,8-Tetrachlorodibenzo- p-dioxin and Related Compounds
- PMID: 28948239
- PMCID: PMC5609723
- DOI: 10.1016/j.cotox.2017.01.010
Beyond the Aryl Hydrocarbon Receptor: Pathway Interactions in the Hepatotoxicity of 2,3,7,8-Tetrachlorodibenzo- p-dioxin and Related Compounds
Abstract
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is the prototypical ligand for a group of environmental halogenated aromatic hydrocarbon contaminants which elicit hepatotoxicity and other toxic responses through activation of the aryl hydrocarbon receptor (AhR). Despite the conservation of the AhR and its signaling pathway, TCDD-elicited differential gene expression networks are species-specific, consistent with differences in sensitivity and toxic responses between species. This review integrates gene expression studies with complementary phenotypic analyses (e.g., metabolomics, clinical biochemistry, and histopathology) to elucidate the pathways through which TCDD and related compounds cause hepatotoxicity beyond AhR activation. We propose that AhR-mediated toxicity is a collective response to the cumulative burden of metabolic reprogramming across multiple pathways. Consequently, nutrition, health status, and genetic background establish the basis for differences in sensitivity and predisposition to adverse outcomes between species, sub-populations, tissues, and cells.
Keywords: Aryl hydrocarbon receptor; Hepatotoxicity; Metabolic Reprogramming; Species-Specific Sensitivity; Toxicogenomics.
Figures


Similar articles
-
Aryl hydrocarbon receptor activation in genital tubercle, palate, and other embryonic tissues in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-responsive lacZ mice.Toxicol Appl Pharmacol. 1998 Jul;151(1):33-44. doi: 10.1006/taap.1998.8444. Toxicol Appl Pharmacol. 1998. PMID: 9705885
-
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) elicited dose-dependent shifts in the murine urinary metabolome associated with hepatic AHR-mediated differential gene expression.bioRxiv [Preprint]. 2024 Oct 25:2024.10.22.619714. doi: 10.1101/2024.10.22.619714. bioRxiv. 2024. PMID: 39484576 Free PMC article. Preprint.
-
Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.J Dermatol Sci. 2014 Jan;73(1):10-22. doi: 10.1016/j.jdermsci.2013.09.001. Epub 2013 Sep 11. J Dermatol Sci. 2014. PMID: 24161567 Free PMC article.
-
The effects of environmental aryl hydrocarbon receptor ligands on signaling and cell metabolism in cancer.Biochem Pharmacol. 2023 Oct;216:115771. doi: 10.1016/j.bcp.2023.115771. Epub 2023 Aug 29. Biochem Pharmacol. 2023. PMID: 37652105 Review.
-
Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR.J Toxicol Environ Health B Crit Rev. 2006 Mar-Apr;9(2):147-71. doi: 10.1080/15287390500196487. J Toxicol Environ Health B Crit Rev. 2006. PMID: 16613807 Review.
Cited by
-
TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobule.bioRxiv [Preprint]. 2023 Jan 8:2023.01.07.523119. doi: 10.1101/2023.01.07.523119. bioRxiv. 2023. Update in: Toxicol Appl Pharmacol. 2023 Jul 15;471:116550. doi: 10.1016/j.taap.2023.116550. PMID: 36711947 Free PMC article. Updated. Preprint.
-
Shift in the urinary metabolome associated with 2,3,7,8-tetrachlorodibenzo-p-dioxin activation of the hepatic aryl hydrocarbon receptor.Sci Rep. 2025 Jul 18;15(1):26035. doi: 10.1038/s41598-025-11772-7. Sci Rep. 2025. PMID: 40676134 Free PMC article.
-
Mechanisms of Environmental Contributions to Fatty Liver Disease.Curr Environ Health Rep. 2019 Sep;6(3):80-94. doi: 10.1007/s40572-019-00232-w. Curr Environ Health Rep. 2019. PMID: 31134516 Free PMC article. Review.
-
TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobule.Toxicol Appl Pharmacol. 2023 Jul 15;471:116550. doi: 10.1016/j.taap.2023.116550. Epub 2023 May 11. Toxicol Appl Pharmacol. 2023. PMID: 37172768 Free PMC article.
-
Analysis of systemic effects of dioxin on human health through template-and-anchor modeling.PLoS Comput Biol. 2025 Mar 27;21(3):e1012840. doi: 10.1371/journal.pcbi.1012840. eCollection 2025 Mar. PLoS Comput Biol. 2025. PMID: 40146780 Free PMC article.
References
-
- Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs) Crit Rev Toxicol. 1990;21:51–88. - PubMed
-
- Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci. 2011;124:1–22. This paper reviews classical and non-classical mechanisms which may contribute to sensitivity differences between species and tissues following ligand-specific activation of AhR signaling. - PMC - PubMed
-
- Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws L, et al. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci. 2006;93:223–241. - PMC - PubMed
-
- van den Berg M, Denison MS, Birnbaum LS, Devito MJ, Fiedler H, Falandysz J, Rose M, Schrenk D, Safe S, Tohyama C, et al. Polybrominated dibenzo-p-dioxins, dibenzofurans, and biphenyls: inclusion in the toxicity equivalency factor concept for dioxin-like compounds. Toxicol Sci. 2013;133:197–208. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources